Trans-membrane peptide therapy for malignant glioma by use of a peptide derived from the MDM2 binding site of p53

Journal of Neuro-Oncology, 05/07/2012

The results suggest that this protein–transduction method using the p53–nuclear localization sequence (NLS)–laminin (Ln)–11R peptide may become a promising glioma therapy as an alternative gene therapy.

Print Article Summary Cat 2 CME Report